Tenax Therapeutics (TENX) Return on Sales (2011 - 2016)

Tenax Therapeutics (TENX) has 5 years of Return on Sales data on file, last reported at 2.96% in Q2 2016.

• For the quarter ending Q2 2016, Return on Sales fell 197.0% year-over-year to 2.96%; the trailing twelve-month figure through Jun 2016 stood at 2.96% (down 290.0% YoY), and the FY2015 full-year result was 4.03%, changed N/A from the prior year.
• Return on Sales retreated to 2.96% in Q2 2016, from 1.01% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.03% in Q4 2012 to a low of 2.96% in Q2 2016.
• A 4-year average of 0.66% and a median of 0.25% in 2012 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales soared 102 bps in 2012 and plunged 197 bps in 2016, its largest moves.
• Tracing TENX's Return on Sales over 4 years: stood at 0.03% in 2012, then slumped by 363 bps to 0.14% in 2013, then tumbled by 620 bps to 1.01% in 2015, then sank by 191 bps to 2.96% in 2016.
• Business Quant data shows TENX's Return on Sales at 2.96% in Q2 2016, 1.01% in Q4 2015, and 0.2% in Q3 2015.